The Foreign Corrupt Practices Act and Pharma in the Chinese Market

September 1, 2010

San Francisco partner Michael Li-Ming Wong and associate Brent Jones are the authors of “The Foreign Corrupt Practices Act and Pharma in the Chinese Market: United States Law Enforcement Pursues Corruption Crackdown Across Entire Industry” [PDF] that was published by GBI in the September 2010 issue of the CPB Review.